US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Bausch + Lomb Corporation Common Shares
(NY:
BLCO
)
19.38
-1.31 (-6.33%)
Official Closing Price
Updated: 7:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch + Lomb Corporation Common Shares
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Expert Ratings for Bausch & Lomb
↗
June 09, 2022
Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
3 Value Stocks That Could 2x in a Recession
↗
June 02, 2022
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022
↗
May 31, 2022
Upgrades
Via
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
↗
May 30, 2022
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022
↗
May 11, 2022
Upgrades
Via
Benzinga
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
↗
May 10, 2022
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022.
Via
InvestorPlace
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow
↗
May 09, 2022
RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous $816...
Via
Benzinga
Opening Day: Bausch + Lomb Pops In Public Debut
↗
May 07, 2022
Shares of Bausch + Lomb rose over 11% to end its first trading day at $20. This was the second biggest IPO of the year. Bausch + Lomb opened at $18.50 after having priced its initial public offering at...
Via
Talk Markets
BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today
↗
May 06, 2022
Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today.
Via
InvestorPlace
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >